Breast cancers can be divided into molecular subtypes, which is based upon the genetic profile of the cancers, but in practice is usually based upon the expression levels of the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67. The gene discussed is ERBB2; the disease is breast carcinoma.